DOCSLIB.ORG

The Influence of Chromatin in DNA-RNA Hybrid Metabolism

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Influence of Chromatin in DNA-RNA Hybrid Metabolism The influence of chromatin in DNA-RNA hybrid metabolism Juan Carlos Martínez Cañas Tesis doctoral Universidad de Sevilla 2020 2 3 4 INDEX Introduction............................................................................................................ 21 1. Sources of DNA damage. ............................................................................... 23 1.1. Replication as a source of genome instability. ........................................ 25 1.2. Transcription as a source of genome instability. ..................................... 29 1.3. Transcription-replication conflicts as a source of genome instability. ...... 31 2. R loops ........................................................................................................... 34 2.1. Factors involved in R loop formation. ...................................................... 36 2.2. The state of the RNA. .............................................................................. 37 2.3. The state of the DNA. .............................................................................. 37 2.4. R loops and genome instability. .............................................................. 39 2.5. Detection of R loops throughout the genome. ......................................... 42 3. Chromatin. ...................................................................................................... 44 3.1. Histone post-translational modifications. ................................................. 45 3.2. Chromatin remodelers. ............................................................................ 48 3.3. Chromatin and DSB repair. ..................................................................... 49 3.4. Chromatin and R loops. .......................................................................... 50 Objectives.............................................................................................................. 55 Results…………………………………………………………………………………….57 Chapter I-Cytosine deamination as a tool to determine DNA-RNA hybrid length, frequency and distribution. .................................................................................... 59 1. H3∆1-28, H3K9-23A and H4K31Q histone mutations that lead to DNA-RNA hybrids do not lead to genome instability unless AID is overexpressed. ............ 61 2. H3K9-23A mutation does not impair replication fork progression and suppresses the replication defects of hpr1∆. ..................................................... 64 3. R loop formation in histone mutants is not related to an altered pattern of nucleosome positioning. .................................................................................... 67 5 4. R loops are similar in size regardless of whether they induce genome instability or not. ................................................................................................. 70 5. Similar R loop length in several R loop-accumulating mutants. .................. 75 6. R loops are formed at a very low frequency. .............................................. 77 7. Bisulfite-qPCR as an alternative method to DRIP ....................................... 79 8. Exploring the use of AID* deaminase in vivo to detect and map R loops. .. 82 9. AID* overexpression induces mutations genome-wide preferentially in large genes and independently of their GC content and expression levels. ............... 86 Chapter II- Effect of the loss of chromatin remodelers and histone modifiers in DNA-RNA hybrid metabolism. ............................................................................... 93 1. Chromatin remodeling mutants do not enhance S9.6 signal. ..................... 95 2. Chromatin remodeling mutants do neither lead to genome instability nor to enhanced sensitivity to AID overexpression ...................................................... 96 3. Rtt109 loss leads to the accumulation of DNA-RNA hybrids. ................... 100 4. Effect of AID* overexpression in rtt109∆ mutant. ...................................... 104 5. Rtt109 prevents DNA-RNA hybrid accumulation through its catalytic activity. ……………………………………………………………………………………106 6. DNA-RNA hybrids accumulate in rtt109∆ cells in all cell cycle phases. .... 108 7. Histone H3 deposition during S phase is not decreased in rtt109∆ mutant ……………………………………………………………………………………109 8. DNA-RNA accumulation in rtt109∆ is independent of the H3K56 acetylation state. ................................................................................................................ 111 9. Mutation of H3K14 and H3K23 (Rtt109 targets) to alanine increases DNA- RNA hybrid accumulation. ............................................................................... 113 10. The genotoxic sensitivity of rtt109∆ mutant is not dependent on DNA-RNA hybrids. ............................................................................................................ 114 6 11. The Rad52 foci accumulation phenotype of rtt109∆ mutant is partially caused by DNA-RNA hybrids. .......................................................................... 115 12. H3K9A mutation is able to suppress the genetic instability of hpr1∆. .... 118 13. The SCR defect of rtt109∆ is not caused by DNA-RNA hybrid accumulation. ................................................................................................... 118 14. rtt109∆ leads to the spontaneous accumulation of DSBs that are not induced by the presence of DNA-RNA hybrids. ............................................... 126 15. Deletion of HPR1 gene in an rtt109∆ background leads to a synergistic effect on genotoxic sensitivity. ......................................................................... 127 Discussion……………………………………………………………………………….129 1. New insights from histone mutants leading to DNA-RNA hybrid accumulation without genetic instability. .................................................................................... 131 2. Setting up the bisulfite deamination assay in yeast reveals that DNA-RNA hybrid length is not a relevant factor for the generation of genetic instability. ..... 132 3. Detection and mapping DNA-RNA hybrids by newly developed S9.6- independent methodologies based on cytosine deamination in vitro and in vivo. 134 4. A model to explain the different phenotypes of R loop-accumulating histone and hpr1∆ mutants. ............................................................................................. 138 5. R loop or related phenotypes not detected in yeast chromatin remodeler mutants. .............................................................................................................. 140 6. A screening among histone modifiers identifies Rtt109 as a new factor leading to DNA-RNA hybrid accumulation. ...................................................................... 141 7. The lack of acetylation of H3K14 and H3K23 contribute to the DNA-RNA hybrid accumulation in rtt109∆. ........................................................................... 142 8. Defective SCR contributes to the DNA-RNA hybrid accumulation of rtt109∆. ………………………………………………………………………………………143 9. A model to explain the DNA-RNA hybrid accumulation of rtt109∆. .............. 146 Conclusions ......................................................................................................... 151 7 Materials and Methods…………………………………………………………………153 Yeast strains, plasmids, primers and antibodies. ............................................. 155 Media used in this study. ................................................................................. 164 Techniques ...................................................................................................... 164 Bacterial transformation. ....................................................................................................... 164 Yeast transformation and gene disruption. ............................................................................ 164 Drop assay. ............................................................................................................................. 164 Plasmid loss assay. ................................................................................................................. 165 Recombination assay. ............................................................................................................. 165 Loss of heterozygocity (LOH) at MAT locus. ........................................................................... 165 Cell viability assay. .................................................................................................................. 166 AID*-induced mutation assay. ................................................................................................ 166 Bioinformatic analyses of AID*-induced mutations. .............................................................. 166 Rad52 foci detection. .............................................................................................................. 167 Cell culture synchronization and FACS analysis. ..................................................................... 167 Protein extraction and western blot. ...................................................................................... 168 Chromosome spreads. ............................................................................................................ 169 CTAB DNA extraction. ............................................................................................................. 169 2D-gel
Load more

Recommended publications
  • A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection
    CLINICAL RESEARCH www.jasn.org A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection Weijia Zhang,1 Zhengzi Yi,1 Karen L. Keung,2 Huimin Shang,3 Chengguo Wei,1 Paolo Cravedi,1 Zeguo Sun,1 Caixia Xi,1 Christopher Woytovich,1 Samira Farouk,1 Weiqing Huang,1 Khadija Banu,1 Lorenzo Gallon,4 Ciara N. Magee,5 Nader Najafian,5 Milagros Samaniego,6 Arjang Djamali ,7 Stephen I. Alexander,2 Ivy A. Rosales,8 Rex Neal Smith,8 Jenny Xiang,3 Evelyne Lerut,9 Dirk Kuypers,10,11 Maarten Naesens ,10,11 Philip J. O’Connell,2 Robert Colvin,8 Madhav C. Menon,1 and Barbara Murphy1 Due to the number of contributing authors, the affiliations are listed at the end of this article. ABSTRACT Background In kidney transplant recipients, surveillance biopsies can reveal, despite stable graft function, histologic features of acute rejection and borderline changes that are associated with undesirable graft outcomes. Noninvasive biomarkers of subclinical acute rejection are needed to avoid the risks and costs associated with repeated biopsies. Methods We examined subclinical histologic and functional changes in kidney transplant recipients from the prospective Genomics of Chronic Allograft Rejection (GoCAR) study who underwent surveillance biopsies over 2 years, identifying those with subclinical or borderline acute cellular rejection (ACR) at 3 months (ACR-3) post-transplant. We performed RNA sequencing on whole blood collected from 88 indi- viduals at the time of 3-month surveillance biopsy to identify transcripts associated with ACR-3, developed a novel sequencing-based targeted expression assay, and validated this gene signature in an independent cohort.
    [Show full text]
  • An Epigenome-Wide Association Study Based on Cell Type
    Integrative Molecular Medicine Research Article ISSN: 2056-6360 An epigenome-wide association study based on cell type- specific whole-genome bisulfite sequencing: Screening for DNA methylation signatures associated with bone mass Shohei Komaki1, Hideki Ohmomo1,2, Tsuyoshi Hachiya1, Ryohei Furukawa1, Yuh Shiwa1,2, Mamoru Satoh1,2, Ryujin Endo3,4, Minoru Doita5, Makoto Sasaki6,7 and Atsushi Shimizu1 1Division of Biomedical Information Analysis, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, 2-1-1 Nishitokuta, Yahaba, Shiwa, Iwate 028-3694, Japan 2Division of Biobank and Data Management, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, 2-1-1 Nishitokuta, Yahaba, Shiwa, Iwate 028-3694, Japan 3Division of Public Relations and Planning, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, 2-1-1 Nishitokuta, Yahaba, Shiwa, Iwate 028-3694, Japan 4Division of Medical Fundamentals for Nursing, Iwate Medical University, 2-1-1 Nishitokuta, Yahaba, Shiwa, Iwate 028-3694, Japan 5Department of Orthopaedic Surgery, School of Medicine, Iwate Medical University, 19-1 Uchimaru, Morioka, Iwate 020-8505, Japan 6Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, 2-1-1 Nishitokuta, Yahaba, Shiwa, Iwate 028-3694, Japan 7Division of Ultrahigh Field MRI, Institute for Biomedical Sciences, Iwate Medical University, 2-1-1 Nishitokuta, Yahaba, Shiwa, Iwate 028-3694, Japan Abstract Bone mass can change intra-individually due to aging or environmental factors. Understanding the regulation of bone metabolism by epigenetic factors, such as DNA methylation, is essential to further our understanding of bone biology and facilitate the prevention of osteoporosis. To date, a single epigenome-wide association study (EWAS) of bone density has been reported, and our knowledge of epigenetic mechanisms in bone biology is strictly limited.
    [Show full text]
  • UNIVERSITY of CALIFORNIA IRVINE Genome-Wide Analysis of NIPBL
    UNIVERSITY OF CALIFORNIA IRVINE Genome-wide analysis of NIPBL/cohesin binding in mouse and human cells: Implications for gene regulation and human disease DISSERTATION Submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in Biomedical Sciences by Daniel Newkirk Dissertation Committee: Professor Kyoko Yokomori, Chair Professor Xing Dai Professor Bogi Anderson Assistant Professor Ali Mortazavi Associate Professor Xiaohui Xie 2015 © Daniel Newkirk 2015 Chapter 2 © 2011 Mary Ann Liebert, Inc., New Rochelle, NY i Dedication This dissertation is dedicated to my family and many friends who have encouraged me to pursue this dream ii Table of Contents Page DEDICATION ii ABBREVIATIONS: v LIST OF FIGURES vi LIST OF TABLES vii ACKNOWLEDGEMENTS viii CURRICULUM VITAE x ABSTRACT xiii CHAPTER 1: Introduction 1 CHAPTER 2: AREM 30 Abstract 31 Introduction 32 Results 35 Discussion 39 Methods 46 References 57 CHAPTER 3: Cornelia de Lange Syndrome 61 Abstract 62 Introduction 63 Results 67 Discussion 98 Methods 104 References 110 CHAPTER 4: NIPBL in HeLa 116 Abstract 117 Introduction 118 Results 120 Discussion 139 Methods 142 References 145 CHAPTER5: FSHD 147 iii Abstract 148 Introduction 150 Results 153 Discussion 168 Methods 169 References 172 CHAPTER 6: Conclusion 174 iv Abbreviations CdLS: Cornelia de Lange Syndrome ChIP-seq: Chromatin immunoprecipitation couple to high- throughput sequencing DEGs: differentially expressed genes DMRs: differentially methylated regions EM: expectation maximization FSHD: Facioscapulohumeral
    [Show full text]
  • Gene Co-Expression Analysis of Human RNASEH2A Reveals Functional Networks Associated with DNA Replication, DNA Damage Response, and Cell Cycle Regulation
    biology Article Gene Co-Expression Analysis of Human RNASEH2A Reveals Functional Networks Associated with DNA Replication, DNA Damage Response, and Cell Cycle Regulation Stefania Marsili, Ailone Tichon, Deepali Kundnani and Francesca Storici * Georgia Institute of Technology, School of Biological Sciences, Atlanta, GA 30332, USA; [email protected] (S.M.); [email protected] (A.T.); [email protected] (D.K.) * Correspondence: [email protected] Simple Summary: RNASEH2A is the catalytic subunit of the ribonuclease (RNase) H2 ternary complex that plays an important role in maintaining DNA stability in cells. Recent studies have shown that the RNASEH2A subunit alone is highly expressed in certain cancer cell types. Via a series of bioinformatics approaches, we found that RNASEH2A is highly expressed in human proliferative tissues and many cancers. Our analyses reveal a possible involvement of RNASEH2A in cell cycle regulation in addition to its well established role in DNA replication and DNA repair. Our findings underscore that RNASEH2A could serve as a biomarker for cancer diagnosis and a therapeutic target. Abstract: Ribonuclease (RNase) H2 is a key enzyme for the removal of RNA found in DNA-RNA hybrids, playing a fundamental role in biological processes such as DNA replication, telomere maintenance, and DNA damage repair. RNase H2 is a trimer composed of three subunits, RNASEH2A Citation: Marsili, S.; Tichon, A.; being the catalytic subunit. RNASEH2A expression levels have been shown to be upregulated in Kundnani, D.; Storici, F. Gene transformed and cancer cells. In this study, we used a bioinformatics approach to identify RNASEH2A Co-Expression Analysis of Human co-expressed genes in different human tissues to underscore biological processes associated with RNASEH2A Reveals Functional RNASEH2A RNASEH2A Networks Associated with DNA expression.
    [Show full text]
  • Camp Response Element-Binding Protein Is a Primary Hub of Activity-Driven Neuronal Gene Expression
    The Journal of Neuroscience, December 14, 2011 • 31(50):18237–18250 • 18237 Cellular/Molecular cAMP Response Element-Binding Protein Is a Primary Hub of Activity-Driven Neuronal Gene Expression Eva Benito,1 Luis M. Valor,1 Maria Jimenez-Minchan,1 Wolfgang Huber,2 and Angel Barco1 1Instituto de Neurociencias de Alicante, Universidad Miguel Herna´ndez/Consejo Superior de Investigaciones Científicas, Sant Joan d’Alacant, 03550 Alicante, Spain, and 2European Molecular Biology Laboratory Heidelberg, Genome Biology Unit, 69117 Heidelberg, Germany Long-lasting forms of neuronal plasticity require de novo gene expression, but relatively little is known about the events that occur genome-wide in response to activity in a neuronal network. Here, we unveil the gene expression programs initiated in mouse hippocam- pal neurons in response to different stimuli and explore the contribution of four prominent plasticity-related transcription factors (CREB, SRF, EGR1, and FOS) to these programs. Our study provides a comprehensive view of the intricate genetic networks and interac- tions elicited by neuronal stimulation identifying hundreds of novel downstream targets, including novel stimulus-associated miRNAs and candidate genes that may be differentially regulated at the exon/promoter level. Our analyses indicate that these four transcription factors impinge on similar biological processes through primarily non-overlapping gene-expression programs. Meta-analysis of the datasets generated in our study and comparison with publicly available transcriptomics data revealed the individual and collective contribution of these transcription factors to different activity-driven genetic programs. In addition, both gain- and loss-of-function experiments support a pivotal role for CREB in membrane-to-nucleus signal transduction in neurons.
    [Show full text]
  • Genetic Architecture of Early Pre-Inflammatory Stage Transcription
    Genetic architecture of early pre-inflammatory stage transcription signatures of autoimmune diabetes in the pancreatic lymph nodes of the NOD mouse reveals significant gene enrichment on chromosomes 6 and 7. Beatrice Regnault, Evie Melanitou To cite this version: Beatrice Regnault, Evie Melanitou. Genetic architecture of early pre-inflammatory stage transcrip- tion signatures of autoimmune diabetes in the pancreatic lymph nodes of the NOD mouse reveals significant gene enrichment on chromosomes 6 and 7.. Meta Gene, Elsevier, 2015, 6, pp.96-104. 10.1016/j.mgene.2015.09.003. pasteur-01441051 HAL Id: pasteur-01441051 https://hal-pasteur.archives-ouvertes.fr/pasteur-01441051 Submitted on 19 Jan 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives| 4.0 International License Meta Gene 6 (2015) 96–104 Contents lists available at ScienceDirect Meta Gene Genetic architecture of early pre-inflammatory stage transcription signatures of autoimmune diabetes in the pancreatic lymph
    [Show full text]
  • A Reference Map of the Human Protein Interactome
    bioRxiv preprint doi: https://doi.org/10.1101/605451; this version posted April 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. A reference map of the human protein interactome Katja Luck1-3,33, Dae-Kyum Kim1,4-6,33, Luke Lambourne1-3,33, Kerstin Spirohn1-3,33, Bridget E. Begg1-3, Wenting Bian1-3, Ruth Brignall1-3, Tiziana Cafarelli1-3, Francisco J. Campos-Laborie7,8, Benoit Charloteaux1-3, Dongsic Choi9, Atina G. Cote1,4-6, Meaghan Daley1-3, Steven Deimling10, Alice Desbuleux1-3,11, Amélie Dricot1-3, Marinella Gebbia1,4-6, Madeleine F. Hardy1-3, Nishka Kishore1,4-6, Jennifer J. Knapp1,4-6, István A. Kovács1,12,13, Irma Lemmens14,15, Miles W. Mee4,5,16, Joseph C. Mellor1,4-6,17, Carl Pollis1-3, Carles Pons18, Aaron D. Richardson1-3, Sadie Schlabach1-3, Bridget Teeking1-3, Anupama Yadav1-3, Mariana Babor1,4-6, Dawit Balcha1-3, Omer Basha19,20, Christian Bowman-Colin2,3, Suet-Feung Chin21, Soon Gang Choi1-3, Claudia Colabella22,23, Georges Coppin1-3,11, Cassandra D'Amata10, David De Ridder1-3, Steffi De Rouck14,15, Miquel Duran-Frigola18, Hanane Ennajdaoui1,4-6, Florian Goebels4,5,16, Liana Goehring2,3, Anjali Gopal1,4- 6, Ghazal Haddad1,4-6, Elodie Hatchi2,3, Mohamed Helmy4,5,16, Yves Jacob24,25, Yoseph Kassa1-3, Serena Landini2,3, Roujia Li1,4-6, Natascha van Lieshout1,4-6, Andrew MacWilliams1-3, Dylan Markey1-3, Joseph N.
    [Show full text]
  • The Roles of the Rnases H and Chromosomal Sequences in DNA:RNA Hybrid Mediated Genome Instability
    The Roles of the RNases H and Chromosomal Sequences in DNA:RNA Hybrid Mediated Genome Instability By Anjali Diana Zimmer A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Molecular and Cell Biology in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Douglas Koshland, Chair Professor Nicholas Ingolia Professor Jasper Rine Professor Daniel Zilberman Summer 2016 Abstract The Roles of the RNases H and Chromosomal Sequences in DNA:RNA Hybrid Mediated Genome Instability by Anjali Diana Zimmer Doctor of Philosophy in Molecular and Cell Biology University of California, Berkeley Professor Douglas Koshland, Chair DNA:RNA hybrids can lead to DNA damage and genome instability. This damage can be prevented by degradation of the RNA in the hybrid by two evolutionarily conserved enzymes, RNase H1 and RNase H2. Indeed, RNase H deficient cells have increased chromosomal rearrangements. However, the quantitative and spatial contributions of the individual enzymes to hybrid removal has been unclear. Additionally, RNase H2 can remove single ribonucleotides misincorporated into DNA during replication. The relative contribution of DNA:RNA hybrids and misincorporated ribonucleotides to chromosome instability was also uncertain. To address these issues, we studied the rate and location of loss of heterozygosity events on chromosome III in Saccharomyces cerevisiae that were defective for RNase H1, H2 or both. We showed that RNase H2 plays the major role in preventing chromosome III instability through its hybrid-removal activity. Furthermore, RNase H2 acts pervasively at many hybrids along the chromosome. In contrast, RNase H1 acts to prevent LOH within a small region of chromosome III, and this instability is dependent upon two hybrid prone regions.
    [Show full text]
  • Data-Driven and Knowledge-Driven Computational Models of Angiogenesis in Application to Peripheral Arterial Disease
    DATA-DRIVEN AND KNOWLEDGE-DRIVEN COMPUTATIONAL MODELS OF ANGIOGENESIS IN APPLICATION TO PERIPHERAL ARTERIAL DISEASE by Liang-Hui Chu A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland March, 2015 © 2015 Liang-Hui Chu All Rights Reserved Abstract Angiogenesis, the formation of new blood vessels from pre-existing vessels, is involved in both physiological conditions (e.g. development, wound healing and exercise) and diseases (e.g. cancer, age-related macular degeneration, and ischemic diseases such as coronary artery disease and peripheral arterial disease). Peripheral arterial disease (PAD) affects approximately 8 to 12 million people in United States, especially those over the age of 50 and its prevalence is now comparable to that of coronary artery disease. To date, all clinical trials that includes stimulation of VEGF (vascular endothelial growth factor) and FGF (fibroblast growth factor) have failed. There is an unmet need to find novel genes and drug targets and predict potential therapeutics in PAD. We use the data-driven bioinformatic approach to identify angiogenesis-associated genes and predict new targets and repositioned drugs in PAD. We also formulate a mechanistic three- compartment model that includes the anti-angiogenic isoform VEGF165b. The thesis can serve as a framework for computational and experimental validations of novel drug targets and drugs in PAD. ii Acknowledgements I appreciate my advisor Dr. Aleksander S. Popel to guide my PhD studies for the five years at Johns Hopkins University. I also appreciate several professors on my thesis committee, Dr. Joel S. Bader, Dr.
    [Show full text]
  • Biomedical Informatics
    BIOMEDICAL INFORMATICS Abstract GENE LIST AUTOMATICALLY DERIVED FOR YOU (GLAD4U): DERIVING AND PRIORITIZING GENE LISTS FROM PUBMED LITERATURE JEROME JOURQUIN Thesis under the direction of Professor Bing Zhang Answering questions such as ―Which genes are related to breast cancer?‖ usually requires retrieving relevant publications through the PubMed search engine, reading these publications, and manually creating gene lists. This process is both time-consuming and prone to errors. We report GLAD4U (Gene List Automatically Derived For You), a novel, free web-based gene retrieval and prioritization tool. The quality of gene lists created by GLAD4U for three Gene Ontology terms and three disease terms was assessed using ―gold standard‖ lists curated in public databases. We also compared the performance of GLAD4U with that of another gene prioritization software, EBIMed. GLAD4U has a high overall recall. Although precision is generally low, its prioritization methods successfully rank truly relevant genes at the top of generated lists to facilitate efficient browsing. GLAD4U is simple to use, and its interface can be found at: http://bioinfo.vanderbilt.edu/glad4u. Approved ___________________________________________ Date _____________ GENE LIST AUTOMATICALLY DERIVED FOR YOU (GLAD4U): DERIVING AND PRIORITIZING GENE LISTS FROM PUBMED LITERATURE By Jérôme Jourquin Thesis Submitted to the Faculty of the Graduate School of Vanderbilt University in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE in Biomedical Informatics May, 2010 Nashville, Tennessee Approved: Professor Bing Zhang Professor Hua Xu Professor Daniel R. Masys ACKNOWLEDGEMENTS I would like to express profound gratitude to my advisor, Dr. Bing Zhang, for his invaluable support, supervision and suggestions throughout this research work.
    [Show full text]
  • Copy Number Networks to Guide Combinatorial Therapy for Cancer and Other Disorders
    bioRxiv preprint doi: https://doi.org/10.1101/005942; this version posted June 24, 2014. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Copy number networks to guide combinatorial therapy for cancer and other disorders Andy Lin and Desmond J. Smith1 Department of Molecular and Medical Pharmacology David Geffen School of Medicine UCLA 23-120 CHS, Box 951735 Los Angeles, CA 90095-1735 USA 1Corresponding author Tel: 310-206-0086 Fax: 310-825-6267 [email protected] bioRxiv preprint doi: https://doi.org/10.1101/005942; this version posted June 24, 2014. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. CNA networks and combinatorial therapy ABSTRACT The dwindling drug pipeline is driving increased interest in the use of genome datasets to inform drug treatment. In particular, networks based on transcript data and protein-protein interactions have been used to design therapies that employ drug combinations. But there has been less focus on employing human genetic interaction networks constructed from copy number alterations (CNAs). These networks can be charted with sensitivity and precision by seeking gene pairs that tend to be amplified and/or deleted in tandem, even when they are located at a distance on the genome.
    [Show full text]
  • Role of Non-Coding Rnas in the Etiology of Bladder Cancer
    G C A T T A C G G C A T genes Review Role of Non-Coding RNAs in the Etiology of Bladder Cancer Caterina Gulìa 1,†, Stefano Baldassarra 1,†, Fabrizio Signore 2, Giuliano Rigon 3, Valerio Pizzuti 4, Marco Gaffi 5, Vito Briganti 5, Alessandro Porrello 6,* and Roberto Piergentili 7,* ID 1 Department of Gynecology, Obstetrics and Urology, Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, Italy; [email protected] (C.G.); [email protected] (S.B.) 2 Department of Obstetrics and Gynaecology, Misericordia Hospital, 58100 Grosseto, Italy; [email protected] 3 Department of Obstetrics and Gynaecology, Azienda Ospedaliera San Camillo-Forlanini, 00152 Rome, Italy; [email protected] 4 Department of Urology, Misericordia Hospital, 58100 Grosseto, Italy; [email protected] 5 Pediatric Surgery and Urology Unit, Azienda Ospedaliera San Camillo-Forlanini, 00152 Rome, Italy; marco.gaffi[email protected] (M.G.); [email protected] (V.B.) 6 Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA 7 Institute of Molecular Biology and Pathology, Italian National Research Council (CNR-IBPM), 00185 Rome, Italy * Correspondence: [email protected] (A.P.); [email protected] (R.P.); Tel.: +1-919-843-8227 (A.P.); +39-06-4991-2827 (R.P.) † These authors contributed equally to this work. Received: 27 August 2017; Accepted: 7 November 2017; Published: 22 November 2017 Abstract: According to data of the International Agency for Research on Cancer and the World Health Organization (Cancer Incidence in Five Continents, GLOBOCAN, and the World Health Organization Mortality), bladder is among the top ten body locations of cancer globally, with the highest incidence rates reported in Southern and Western Europe, North America, Northern Africa and Western Asia.
    [Show full text]